NCT07813702 URINARY INCONTINENCE AND GERIATRIC SYNDROMES
| NCT ID | NCT07813702 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MERT UYSAL |
| Condition | Urinary Incontinence (UI) |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-04-08 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2026-04-08 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this cross-sectional observational study is to examine the independent associations of urinary incontinence severity and post-void residual urine volume with frailty and other geriatric outcomes in older adults presenting to a urology outpatient clinic with urinary incontinence.
Eligibility Criteria
Inclusion Criteria: * Age 65 years or older, * Presence of involuntary urinary leakage according to the International Continence Society definition, * At least one urinary leakage episode during the previous four weeks and an ICIQ-UI SF score of ≥1, * General health status adequate to tolerate the outpatient assessment protocol, * Ability to mobilize independently, * Ability to understand instructions in Turkish and complete the study questionnaires, * Willingness to participate and provision of written informed consent. Exclusion Criteria: * Acute urinary tract infection or acute lower urinary tract symptoms, * History of major pelvic or orthopedic surgery within the previous six months, * Acute musculoskeletal condition that may affect performance during the assessments, * Neurological disease causing severe mobility limitations, including Parkinson's disease or stroke, * Diabetic neuropathy, * Severe cardiopulmonary disease, including New York Heart Association class III-IV heart failure or forced expiratory volume in one second below 30% of the predicted value, * Dementia or severe cognitive impairment, defined as Global Deterioration Scale stage 4 or higher, * Severe visual or hearing impairment that may prevent completion of the assessments, * Terminal illness or active malignancy, * Inability or unwillingness to provide informed consent, * Unwillingness or inability to complete the assessment protocol.
Contact & Investigator
Eylem Tutun Yumin, Professor
STUDY CHAIR
Abant Izzet Baysal University
Frequently Asked Questions
Who can join the NCT07813702 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Urinary Incontinence (UI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07813702 currently recruiting?
Yes, NCT07813702 is actively recruiting participants. Contact the research team at mertuysal@karabuk.edu.tr for enrollment information.
Where is the NCT07813702 trial being conducted?
This trial is being conducted at Karabük, Turkey (Türkiye).
Who is sponsoring the NCT07813702 clinical trial?
NCT07813702 is sponsored by MERT UYSAL. The principal investigator is Eylem Tutun Yumin, Professor at Abant Izzet Baysal University. The trial plans to enroll 120 participants.